It has been reported that radicicol and novobiocin induce the degradation of the HSP90 client protein CRAF but do not degrade BRAFV600E or inhibit MEK1/2 activation in HT29 human colon cancer cells [34]. The gene discussed is RAF1; the disease is colonic neoplasm.